Drug Type Polysaccharide |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism DR4 antagonists(Tumor necrosis factor receptor superfamily member 10A antagonists), TRAIL inhibitors(Tumor necrosis factor ligand superfamily member 10 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Ductal Adenocarcinoma | Preclinical | China | 30 Aug 2025 |





